Lisata Therapeutics, Inc.
LSTA
$5.03
-$0.01-0.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.01% | 12.04% | 10.19% | 3.72% | 4.10% |
| Total Depreciation and Amortization | -16.09% | -4.44% | -8.11% | -8.56% | -7.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.89% | 49.09% | 103.46% | 45.58% | 22.85% |
| Change in Net Operating Assets | -47.42% | -195.67% | 376.16% | -128.13% | -88.96% |
| Cash from Operations | 17.60% | 8.83% | 17.82% | 6.00% | 3.37% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 14.21% | 169.22% | -79.55% | 32.71% | 30.99% |
| Cash from Investing | 14.00% | 168.76% | -79.67% | 32.48% | 30.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,152.94% | 1,119.64% | 489.29% | -39.50% | -85.71% |
| Repurchase of Common Stock | 7.66% | -171.13% | -160.14% | -153.38% | -201.10% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 390.78% | 446.51% | 40.22% | -126.52% | -153.51% |
| Foreign Exchange rate Adjustments | 120.00% | 15.15% | 36.67% | 103.13% | -243.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.04% | 96.04% | -348.92% | 74.99% | 33.23% |